Original Research Article
Evaluation and assessment of clinical and demographic profile, aetiology and outcome of status epilepticus in paediatric patients
Department of Pediatrics, GMERS Medical College, Valsad, Gujarat, India
Received: 09 February 2023
Revised: 07 March 2023
Accepted: 13 March 2023
*Correspondence:
Dr. Nirav Z. Garasiya,
E-mail: drnzg63@gmail.com
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Background: Status epilepticus (SE) is one of the most frequent neurological emergencies that require prompt diagnosis and treatment. If not managed promptly, it may result in significant neurological morbidity and mortality.
Methods: It is prospective observational study. Study for clinical and demographic profile, aetiology, outcome in patient of status epilepticus.
Results: Occurrence of SE is in indoor paediatric patients was 2.05%. Male and female M: F ratio is 1.3:1. Fever was common associated symptoms in SE. The commonest type of seizure was generalised tonic-clonic seizure (GTCS). Infective etiology was most common amongst patients with SE. secondary epilepsy with CP was second most common cause followed by complex febrile seizure and primary epilepsy. In infants, metabolic etiology was the most common cause for SE. Majority of seizures were controlled only by benzodiazepines. Requirement of midazolam infusion was only in few patients and requirement of anesthetic agent was rare. Mechanical ventilation was frequently required in patients with refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE). Mortality was almost same in all age groups with SE. Mortality was directly proportional to duration of the SE and was highest in patient having >30 minutes of duration of seizure.
Conclusions: SE was more commonly associated with male gender and age <5 years. By improving hygiene, nutritional and vaccination status, overcrowding and education, we can reduce occurrence of SE, by reducing infections. Mortality can be reduced by immediate control of seizure and improving intensive care facilities.
Keywords: Refractory status epilepticus, Super-refractory status epilepticus
INTRODUCTION
Status epilepticus (SE) is one of the most frequent neurological emergencies that require prompt diagnosis and treatment. If status epilepticus not managed promptly and curiously which may result in significant neurological morbidity and mortality.1
SE is a condition resulting either from the failure of the mechanism responsible for seizure termination or from the initiation of mechanism which lead to abnormally prolonged seizures. SE may lead consequences including neuronal injury, alteration of neuronal networks and neuronal death. All consequences are depending on types and duration of seizures.2,3
SE is associated with risks of decline in quality of life and cognition with 30 days’ mortality, ranging from 9.4% to 27%.2,3 Status epilepticus or prolonged seizures are associated with highest mortality and worse clinical outcomes, therefore effective and immediate treatment according to cause should be initiated as soon as possible to prevent its consequences.4,5
International league against epilepsy (ILAE) defined as single or recurrent seizure lasting for more than 30 minutes during which consciousness is not regained. But in current scenario being recognized that even a 10 minutes’ seizure activity can lead to brain damage, therefore the duration of a seizure required to define status epilepticus is being reduced.
Particularly, the most seizures resolve within few minutes. So, duration of seizures continuing more than 5 minutes should probably be treated as status epilepticus.
Aims and objectives
Evaluation and assessment of clinical and demographic profile of patients admitted with status epilepticus. Study for aetiology of status epilepticus, outcome and mortality in patient of status epilepticus.
METHODS
Type of study
Prospective observational study, done at tertiary care level, Sheth L.G. hospital, Ahmedabad, Gujarat, India.
Study period
The period of the study was from 01 July 2018 to 31 December 2018.
Inclusion criteria
All patients between 1 month to 14 years of age admitted in pediatric ward having status epilepticus were included in the study.
Exclusion criteria
Neonates up to 1 months of age and children more than 14 years of age were excluded.
All patients were stabilized and managed as per standard protocol. Vitals of the patients were noted at the time of admission and detailed neurological examination was performed during admission or after initial stabilization of patient when sedative effects of anticonvulsants drugs were over.
Clinical and demographic profile of each patient was documented. Detail of history, examination findings and investigations were documented. Patients were observed till discharge or death. Any complication during course of hospital stay were documented.
Ultimate outcome of each patient was documented as discharge, DAMA, or death. Data was compiled and analysed by standard statistical methods, P value and chi square test applied wherever required by statistics analyst in our hospital. Ethical approval was not required as no fund was required for this study and all investigations and treatment were totally free as government hospital.
RESULTS
A total number of 7292 patients were admitted in the pediatric ward of tertiary care institute during study period. Among these 1570 had various types of CNS disorders and out of them 150 were having SE. Occurrence of SE is 2.05% in indoor paediatric patients.
In present study, 85 (56.7%) were male and 65 (43.3%) were female with male: female ratio of 1.3: 1 (Table 1).
Most patients were falling in age group of 1 month to 5 years (67.3%) (Table 2).
Fever was the most common symptom associated with the patients of SE and it was seen in 72 (48%), followed by altered sensorium in 23 (15.3%). Other common associated symptoms were cough and cold, vomiting, diarrhoea, headache, respiratory distress, bleeding and ear discharge (Table 3).
The most common type of seizure presented with SE was generalised tonic-clonic seizure (GTCS) in 110 patients (73.4%), followed by focal in 35 (30.7%). Other less common types were generalised tonic 3 (2%), myoclonic 1 (0.6%) and absent 1 (0.6%) (Table 4).
The most common etiology of SE was infective 47 (31.33%). Amongst them, viral encephalitis was 15 (10%) the most common infection. Other infective causes were neurocysticercosis, tubercular meningitis, pyogenic meningitis, tuberculoma, dengue encephalitis and enteric encephalopathy.
Secondary epilepsy due to perinatal insult 31 (20.67%) was second most common cause of SE.
Complex febrile seizure 22 (14.67%) and primary epilepsy 22 (14.67%) were also important causes of SE in this study.
11 (7.33%) patients were having metabolic etiology for SE, out of them hypocalcemia was the most common. Other metabolic causes were hypoglycaemia and electrolyte disturbances.
Other less common causes 17 (11.33%) were autoimmune, hydrocephalus, vascular diseases, storage disorders and congenital malformations (Table 5).
The most common cause of SE in 1 month to 1 year was metabolic (33.4%). Perinatal insult and CP (27.3%) was the commonest cause of SE in 1 year to 5 years of age group. The commonest cause of SE was infective in 5 to 10 years (46%) and >10 years’ age group (75%). Most cases of complex febrile seizure presenting with SE were seen in 1 year to 5-year age group (63.6%). 50% cases of primary epilepsy with SE were seen in 1 year to 5-year age group. Infective etiology was important cause of SE in all age groups (Table 6).
In 76 (50.7%) patients, seizure subsided by Benzodiazepine followed by 1st group antiepileptic drugs in 41 (27.3%) and by 2nd group antiepileptic drugs in 27 (18%). Midazolam infusion was required in 3.3% and anaesthetic agent was required in 1 patient (0.7%).
Out of 150 patients 32 (21.3%) were having refractory SE and 1 (0.7%) patient was having super-refractory SE.
Requirement of mechanical ventilatory support was higher in refractory (37.5%) and super refractory status epilepticus (100%) compared to SE and it was statistically significant (p<0.001). Out of 150 patients, only 57 (38%) patients required oxygen for more than 24 hours (Table 8).
There was no significant difference (p>0.5) in mortality in different age groups having SE (Figure 1).
In present study, mortality was directly proportional to duration of SE. Mortality was the highest in patients having seizure duration more than 30 minutes (18.5%) (Table 9).
In present study, mortality was high in refractory status epilepticus (18.8%) and super refractory status epilepticus (100%) as compared to SE (5.2%) and it was statistically significant (p<0.001) (Figure 2).
High mortality was seen with metabolic etiology (18.2%), followed by infective (12.7%). No mortality was observed in primary epilepsy. Mortality was 6.4% in patients with secondary epilepsy with cerebral palsy and was 4.5% in complex partial seizures (Table 10).
Out of 150 patients, 132 (88%) were discharged while 13 (8.7%) expired. Rest of them, 4 (2.7%) were discharged against medical advised due to their social issues & 1 child was known case of chronic kidney disease and referred to higher centre for hemodialysis. So, mortality in our study is 8.7% (Figure 3).
DISCUSSION
Occurrence of SE is in indoor paediatric patients was 2.05%. In this study M: F ratio of 1.3:1. Similar study done by Kumar et al have observed male: female ratio of 1.5: 1.6
In another study done by Selvan et al, male: female ratio was 1.06: 1.7 We could not find any definite reason for male predominance for status epilepticus in literature.
Majority (67.3%) of patients were falling in age group of 1 month to 5 years. Selvan et al observed that the most common affected age group was 1 to 3 years (54.54%).7 Kumar et al also observed that the most common affected age group was 2 to 4 years (43%).6 The reason for this predominance of SE in younger children <5 years is not known exactly, but probably, mechanisms for control of seizure activity are fragile in younger children and may get disrupted with minimal abnormalities in neuro-function.
Fever was common associated symptoms in SE (48%). Das et al also observed that fever was most common symptom associated with SE and mostly seen in younger age group of children <5 years.8 This may be because acute infections are important cause of SE in all age groups.
Most common type of seizure is GTCS. In study by Das et al, most common type of seizure presenting with SE was GTCS 30 (75%), followed by focal 8 (25%).8 Gulati et al also observed that most common seizure type was GTCS 19 (63.6%), followed by focal 8 (26.6%).9
Infective etiology was most common (31.33%) amongst patients with SE. Kumar et al also observed that predominant cause of SE was CNS infection, in which Viral encephalitis 11 (33.33%)was the leading cause.6 Other study by Lingappa et al also observed CNS infection 88.1% (n=37) as a most common cause.10 In developing countries acute symptomatic aetiology is common cause of SE. Infections are common in developing countries compared to developed countries probably due to poor health status, poor hygiene, poor nutrition, poor vaccination, illiteracy and poor drug compliance. So in children proper diet, vaccination, good hygiene and good quality of life can decrease incidence of SE.
Majority of seizures were controlled only by benzodiazepines that means early or as soon as initiation of treatment for SE may decline mortality and consequences. Mortality was almost same in all age groups with SE but it was directly proportional to duration of the SE and was highest (18.5%) in patient having >30 minutes of duration of seizure and also observed that mortality was high in RSE (18.8%) and 100% in SRSE. Gulati et al also observed that patients who experienced seizure activity >45 minutes had high mortality.9 With longer duration of seizure, the cerebral autoregulation fails progressively. It leads to decreased cerebral blood flow resulting in hypoxia, cerebral ischemia, hypoglycaemia, lactic acidosis. All these contribute to high mortality.11
In our study mortality of SE was 8.7%. Das et al observed mortality of 15% (n=6/40).8 Madhu et al observed mortality of 26.4% (n=23/87) and Kumar et al observed mortality of 31.4% (n=22/70).6,12 Risk factors of mortality observed in this study were younger age group, longer duration of SE, poor response to initial anticonvulsants and prolonged requirement of ventilator support.
CONCLUSION
SE is an emerging condition in children, in management requires simultaneous resuscitation and medical stabilization by anti-epileptic drugs, diagnosis of the underlying cause, and definitive rapid treatment of both clinical and electrographic seizures. By improving hygiene, nutritional and vaccination status, overcrowding and education, we can reduce occurrence of SE, by reducing infections. Mortality is directly proportional to duration of requirement of mechanical ventilation in refractory and super refractory SE with prolonged duration of seizure. So, mortality can be reduced by immediate control of seizure and improving intensive care facilities.
Funding: No funding sources
Conflict of interest: None declared
Ethical approval: The study was approved by the Institutional Ethics Committee
REFERENCES
- 1. Treatment of convulsive status epilepticus, Recommendations of Epilepsy foundation of america’s working group on status epilepticus. JAMA. 1993;270:854-9.
- 2. Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilesia 2006;47:1499-50.
- 3. Tomson T. Mortality in Epilepsy. J Neurol. 2000;247:15-21.
- 4. Brophy GM, Bell R, Claassen J, Alldredge B, Black TP, Glauses T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit case. 2012;17:3-23.
- 5. Glauses T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence base guideline, treatment of convulsive status epilepticus in children & adults. Repost of the guideline committee of American epilepsy society. Epilepsy Curr. 2016;16:48-6.
- 6. Kumar M, Kumari R, Narain NP. Clinical profile of status epilepticus in children in a tertiary care hospital in Bihar. J Clin Diagnost Res. 2014;8:14-7.
- 7. Selvan T, Nagraj MV, Saravanan P, Tudu MN. A Study of the etiology and short term outcome of status epilepticus in children. Indian J Contemp Paediatrics. 2017;4:878-81.
- 8. Das NK, Soren B, Gupta D. Clinical Profile, Aetiology and Short Term Outcome of convulsive status epilepticus in children in Eastern India. JMSCR. 2017;5:15912-6.
- 9. Gulati S, Kalra V, Shridhar MR. Status Epilepticus in Indian children in a Tertiary care centre, Indian J Paediatrics. 2005;72:105-8.
- 10. Lingappa L, Konanki R, Patel R, Vooturi S, Jayalaxmi S. Clinical Profile and Outcome of Refractory Convulsive status Epilepticus in older children from a developing Country. Seizure. 2016;36:31-5.
- 11. Mishra D, Sharma S, Sankhyan N, Konanki R, Kamate M, Kanhere S, et al. Consensus Guidelines on Management of Childhood Convulsive Status Epilepticus. Indian Pediatrics. 2014;51:975-90.
- 12. Madhu PK, Krithika R. Convulsive Status Epilepticus in Children: Clinical Profile and Outcome in a Tertiary Care Hospital. Int J Contemp Pediatrics. 2019;6(2):280-7.